journal
https://read.qxmd.com/read/39391591/efficacy-and-safety-of-telitacicept-a-blys-april-dual-inhibitor-in-the-treatment-of-iga-nephropathy-a-retrospective-case-control-study
#1
JOURNAL ARTICLE
Meng Wang, Jianfei Ma, Li Yao, Yi Fan
BACKGROUND: Telitacicept, a B lymphocyte stimulator/A proliferation-inducing ligand dual-target fusion protein, has recently been used in autoimmune diseases. We assessed the efficacy and safety of telitacicept in immunoglobulin A nephropathy (IgAN) patients. METHODS: This study included 42 IgAN patients who received telitacicept treatment, forming the 'whole telitacicept group'. Among them, 20 patients who had not previously received corticosteroid (CS) therapy or immunosuppressive (IS) agents were categorized as the 'newly treated telitacicept subgroup'...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39391590/non-dilated-obstructive-nephropathy
#2
REVIEW
Valeria Feliciangeli, Annalisa Noce, Giulia Montalto, Stefano Germani, Roberto Miano, Anastasios D Asimakopoulos
Obstructive nephropathy (ON) is a common and reversible cause of post-renal acute kidney injury (AKI) and may be caused by a variety of conditions. It occurs when both the upper urinary tracts are obstructed, or when one tract is obstructed in patients with a solitary kidney. ON is suspected whenever there is evidence of hydronephrosis at imaging. However, not all patients with obstruction develop hydronephrosis and significant obstruction can be present in the absence of hydronephrosis. This syndrome is called non-dilated obstructive uropathy (NDOU)...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39385948/the-benefit-of-reduced-serum-phosphate-levels-depends-on-patient-characteristics-a-nationwide-prospective-cohort-study
#3
JOURNAL ARTICLE
Shunsuke Goto, Takayuki Hamano, Hideki Fujii, Masatomo Taniguchi, Masanori Abe, Kosaku Nitta, Shinichi Nishi
BACKGROUND: In cohort studies of hyperphosphatemic hemodialysis patients, reduced serum phosphate levels have been linked to a lower mortality risk. To investigate whether this benefit is influenced by patient characteristics, we calculated the number needed to be exposed (NNE), stratified by patient characteristics. METHODS: In this 9-year prospective cohort study using the nationwide Japanese registry, we enrolled 78 256 hemodialysis patients aged 18 years or older...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39385947/machine-learning-models-for-mortality-prediction-in-critically-ill-patients-with-acute-pancreatitis-associated-acute-kidney-injury
#4
JOURNAL ARTICLE
Yamin Liu, Xu Zhu, Jing Xue, Rehanguli Maimaitituerxun, Wenhang Chen, Wenjie Dai
BACKGROUND: The occurrence of acute kidney injury (AKI) was associated with an increased mortality rate among acute pancreatitis (AP) patients, indicating the importance of accurately predicting the mortality rate of critically ill patients with acute pancreatitis-associated acute kidney injury (AP-AKI) at an early stage. This study aimed to develop and validate machine learning-based predictive models for in-hospital mortality rate in critically ill patients with AP-AKI by comparing their performance with the traditional logistic regression (LR) model...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39385946/the-effects-of-dialysate-calcium-prescription-on-mortality-outcomes-in-incident-patients-on-hemodialysis
#5
JOURNAL ARTICLE
Karlien J Ter Meulen, Paola Carioni, Francesco Bellocchio, Frank M van der Sande, Heleen J Bouman, Stefano Stuard, Luca Neri, Jeroen P Kooman
BACKGROUND: The appropriate prescription of dialysate calcium concentration for hemodialysis is debated. We investigated the association between dialysate calcium and all-cause, cardiovascular mortality and sudden cardiac death. METHODS: In this historical cohort study, we included adult incident hemodialysis patients who initiated dialysis between 1 January 2010 and 30 June 2017 who survived for at least 6 months (grace period). We evaluated the association between dialysate calcium 1...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39376682/associations-between-acute-kidney-injury-and-bone-fractures-a-retrospective-cohort-study
#6
JOURNAL ARTICLE
Hicham I Cheikh Hassan, Bridie S Mulholland, Brendan McAlister, Kelly Lambert, Karumathil M Murali, Stephen Moules, Judy Mullan
BACKGROUND: Acute kidney injury (AKI) is common. An AKI episode may disrupt the normal mineral bone balance maintained by normal kidney function, thereby modifying the risk of developing bone fractures. However, it remains unclear whether an AKI episode is associated with the risk of bone fractures. METHODS: Using retrospective cohort study from an Australian Local Health District, we examined the association between an AKI episode and bone fractures using patient data between 2008 and 2017...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39376681/sex-and-gender-differences-in-health-related-quality-of-life-in-individuals-treated-with-incremental-and-conventional-hemodialysis
#7
JOURNAL ARTICLE
Victoria J Riehl-Tonn, Jennifer M MacRae, Sandra M Dumanski, Meghan J Elliott, Neesh Pannu, Kara Schick-Makaroff, Kelsea Drall, Colleen Norris, Kara A Nerenberg, Louise Pilote, Hassan Behlouli, Taryn Gantar, Sofia B Ahmed
BACKGROUND: Women treated with hemodialysis report lower health-related quality of life (HRQoL) compared with men. Whether this is related to sex-specific (biological) (e.g. under-dialysis due to body composition differences) or gender-specific (sociocultural) factors (e.g. greater domestic/caregiver responsibilities for women) is unknown. We examined the association between sex assigned at birth, gender score and HRQoL in individuals initiating conventional and incremental hemodialysis...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39372237/how-to-make-a-shared-decision-with-older-persons-for-end-stage-kidney-disease-treatment-the-added-value-of-geronto-nephrology
#8
REVIEW
Florent Guerville, Marion Pépin, Antoine Garnier-Crussard, Jean-Baptiste Beuscart, Salvatore Citarda, Aldjia Hocine, Cédric Villain, Thomas Tannou
Improving care for older people with end-stage kidney disease (ESKD) requires the adaptation of standards to meet their needs. This may be complex due to their heterogeneity in terms of multimorbidity, frailty, cognitive decline and healthcare priorities. As benefits and risks are uncertain for these persons, choosing an appropriate treatment is a daily challenge for nephrologists. In this narrative review, we aimed to describe the issues associated with healthcare for older people, with a specific focus on decision-making processes; apply these concepts to the context of ESKD; identify components and modalities of shared decision-making and suggest means to improve care pathways...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39372236/post-transplant-renal-anemia-a-call-to-action-from-a-national-study-in-routine-clinical-practice
#9
JOURNAL ARTICLE
Jose Portoles, Marta Crespo, Miguel Martínez Belotto, Eduardo Martínez Morales, Emma Calatayud Aristoy, Paula Mora Lopez, Sthefanny Carolina González Garcia, Laia Oliveras, Julio Colina, Arhsdeep Singh, Asunción Sancho Calabuig, Emilio Rodrigo Calabia, Nuria Montero, Alex Gutierrez-Dalmau, Auxiliadora Mazuecos, Julio Pascual
BACKGROUND: Post-transplant anemia is a prevalent yet often overlooked condition that poses significant risks. Current guidelines consider the same treatment recommendations and goals for these patients as for chronic kidney disease patients not on dialysis. Previous reports demonstrated a lack of awareness and suboptimal management, indicating a pressing need for improvement. We therefore wanted to update the information on post-transplant anemia. We aimed to describe the present state of anemia management, goals and adherence to guidelines within a representative sample of the kidney transplant (KTx) population...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39359568/kidney-effects-of-triple-cftr-modulator-therapy-in-people-with-cystic-fibrosis
#10
JOURNAL ARTICLE
Pierre Gabai, Etienne Novel-Catin, Quitterie Reynaud, Raphaële Nove-Josserand, Solenne Pelletier, Denis Fouque, Laetitia Koppe, Isabelle Durieu
BACKGROUND: Elexacaftor/tezacaftor/ivacaftor (ETI) is a new cystic fibrosis transmembrane conductance regulator (CFTR) modulator that has transformed the respiratory prognosis of people with cystic fibrosis (pwCF). However, its impact on other organs such as the kidneys, where CFTR is expressed, remains unclear. Since pwCF are risk of both kidney disease and urolithiasis, we aimed to study the potential effects of ETI on renal function, volume status, and risk factors for urolithiasis...
October 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39345687/correction-to-biomarkers-in-clinical-epidemiology-studies
#11
COMMENT
(no author information available yet)
[This corrects the article DOI: 10.1093/ckj/sfae130.].
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39329073/validation-of-arteriovenous-access-stage-avas-classification-a-prospective-international-multicentre-study
#12
JOURNAL ARTICLE
Katerina Lawrie, Petr Waldauf, Peter Balaz, Ricardo Lacerda, Emma Aitken, Krzysztof Letachowicz, Mario D'Oria, Vittorio Di Maso, Pavel Stasko, Antonio Gomes, Joana Fontainhas, Matej Pekar, Alena Srdelic, Stephen O'Neill
BACKGROUND: The arteriovenous access stage (AVAS) classification provides evaluation of upper extremity vessels for vascular access (VA) suitability. It divides patients into classes within three main groups: suitable for native fistula (AVAS1) or prosthetic graft (AVAS2), and patients not suitable for conventional native or prosthetic VA (AVAS3). We validated this system on a prospective dataset. METHODS: A prospective, international observational study (NCT04796558) involved 11 centres from 8 countries...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39323731/the-impact-of-severe-nephrotic-syndrome-on-thyroid-function-nutrition-and-coagulation
#13
JOURNAL ARTICLE
Anna Matyjek, Stanisław Niemczyk, Sławomir Literacki, Wojciech Fendler, Tomasz Rozmysłowicz, Andreas Kronbichler
BACKGROUND: Nephrotic syndrome (NS) is characterized by urinary loss of proteins, including hormones and their carrier proteins, potentially resulting in endocrine disorders. This study aimed to assess thyroid dysfunction frequency and potential implications in NS. METHODS: In this case-control study, patients with severe NS (serum albumin ≤2.5 g/dl) and controls without proteinuria were evaluated for thyroid, haemostatic and nutritional parameters, including body composition...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39323730/kidney-re-transplantation-in-the-ipsilateral-iliac-fossa-a-surgeon-s-perspective-on-perioperative-outcome
#14
JOURNAL ARTICLE
Philipp Tessmer, Clara A Weigle, Anna Meyer, Bengt A Wiemann, Wilfried Gwinner, Gunilla Einecke, Jürgen Klempnauer, Florian W R Vondran, Nicolas Richter, Felix Oldhafer, Oliver Beetz
BACKGROUND: Compared with primary transplantation, ipsilateral renal re-transplantation is associated with an increased risk of surgical complications and inferior graft outcomes. This study investigates whether an ipsilateral re-transplantation approach per se is an independent risk factor for surgical complications and early graft loss. METHODS: In this retrospective, single-centre analysis, surgical complications and early graft outcomes of ipsilateral kidney re-transplantations from January 2007 to December 2017 were compared with primary transplantations and contralateral re-transplantations...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39319306/the-role-of-blood-purification-therapies-in-the-treatment-of-chronic-kidney-disease-associated-pruritus-a-systematic-review
#15
REVIEW
Matteo Marcello, Davide Marturano, Claudio Ronco, Monica Zanella
Chronic kidney disease-associated pruritus (CKD-aP) is a common complication in dialysis patients which is not fully addressed by pharmacological and dialytic therapy. The objective was to review the literature on the effects of extracorporeal blood purification modalities on CKD-aP. The population comprised patients aged ≥18 years on chronic dialysis. PubMed, Embase, and Medline were systematically searched until February 2024 for clinical studies comparing the effect of different dialysis modalities on pruritus intensity...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39314869/estimating-glomerular-filtration-in-young-people
#16
COMMENT
Pierre Delanaye, Laurence Derain-Dubourg, Jonas Björk, Marie Courbebaisse, Lionel Couzi, Francois Gaillard, Cyril Garrouste, Anders Grubb, Lola Jacquemont, Magnus Hansson, Nassim Kamar, Christophe Legendre, Karin Littmann, Christophe Mariat, Lionel Rostaing, Andrew D Rule, Per-Ola Sundin, Arend Bökenkamp, Ulla Berg, Kajsa Åsling-Monemi, Anna Åkesson, Anders Larsson, Ulf Nyman, Hans Pottel
BACKGROUND: Creatinine-based equations are the most used to estimate glomerular filtration rate (eGFR). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), the re-expressed Lund-Malmö Revised (r-LMR) and the European Kidney Function Consortium (EKFC) equations are the most validated. The EKFC and r-LMR equations have been suggested to have better performances in young adults, but this is debated. METHODS: We collected data (GFR) measured by clearance of an exogenous marker (reference method), serum creatinine, age and sex from 2366 young adults (aged between 18 and 25 years) both from Europe and the USA...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39314868/basiliximab-induction-alone-vs-a-dual-atg-basiliximab-approach-in-first-live-donor-non-sensitized-kidney-transplant-recipients-with-low-hla-matching
#17
JOURNAL ARTICLE
Tammy Hod, Shmuel Levinger, Enosh Askenasy, Maya Siman-Tov, Yana Davidov, Ronen Ghinea, Niv Pencovich, Ido Nachmani, Eytan Mor
BACKGROUND: Individualizing induction therapy based on immunological risk is crucial for optimizing outcomes in kidney transplantation. METHODS: A retrospective analysis included 157 first live-donor non-sensitized kidney transplant recipients (KTRs). Within this cohort, 96 individuals exhibited low human leukocyte antigen (HLA) matching (5-6 HLA mismatches). The low HLA match subgroup was categorized into 52 KTRs receiving basiliximab alone and 44 recipients treated with a combined single ATG dose of 1...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39301272/short-term-peritoneal-rest-reduces-peritoneal-solute-transport-rate-and-increases-ultrafiltration-in-high-high-average-transport-peritoneal-dialysis-patients-a-crossover-randomized-controlled-trial
#18
JOURNAL ARTICLE
Bei Wu, Huiping Zhao, Li Zuo, Aichun Liu, Lixia Lu, Jie Qiao, Xinxin Chu, Chuncui Men, Yuting He
BACKGROUND: The peritoneal solute transport rate (PSTR) tends to increase over time in some patients undergoing peritoneal dialysis (PD), potentially leading to ultrafiltration (UF) failure. Previous case reports have shown a significant decrease in PSTR and subsequent recovery of UF after discontinuing PD for a while. Therefore, we conducted a randomized controlled crossover study to evaluate the impact of short-term peritoneal rest on PSTR. METHODS: The study involved 14 continuous ambulatory peritoneal dialysis (CAPD) patients with high/high-average transport rate...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39301271/transportable-portable-wearable-and-partially-implantable-haemodialysis-systems-comparison-of-technologies-and-readiness-levels
#19
REVIEW
Fokko P Wieringa, Dian Bolhuis, Henning Søndergaard, Stephen R Ash, Cian Cummins, Karin G F Gerritsen, Jeroen Vollenbroek, Tugrul Irmak
BACKGROUND: Dialysis modalities and their various treatment schedules result from complex compromises ('trade-offs') between medical, financial, technological, ergonomic, and ecological factors. This study targets summarizing the mutual influence of these trade-offs on (trans)portable, wearable, or even (partially) implantable haemodialysis (HD) systems, identify what systems are in development, and how they might improve quality of life (QoL) for patients with kidney failure. METHODS: HD as defined by international standard IEC 60601-2-16 was applied on a PUBMED database query regarding (trans)portable, wearable, and (partly) implantable HD systems...
September 2024: Clinical Kidney Journal
https://read.qxmd.com/read/39295966/immobilization-associated-hypercalcaemia-in-patients-with-malignancy-in-the-hospital-setting
#20
JOURNAL ARTICLE
Swetha R Kanduri, Anabella Stark, Juan Carlos Q Velez
No abstract text is available yet for this article.
September 2024: Clinical Kidney Journal
journal
journal
43966
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.